Article info
Rheumatoid arthritis
Editorial
JAK inhibition and the holy grail for pain control in early RA
- Correspondence to Dr René Westhovens; rene.westhovens{at}uzleuven.be
Citation
JAK inhibition and the holy grail for pain control in early RA
Publication history
- Received December 2, 2021
- Accepted January 17, 2022
- First published January 28, 2022.
Online issue publication
June 08, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.